BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 21343381)

  • 1. Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer.
    Cheng WL; Wang CS; Huang YH; Tsai MM; Liang Y; Lin KH
    Ann Oncol; 2011 Oct; 22(10):2267-76. PubMed ID: 21343381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro.
    Li Z; Wang Y; Dong S; Ge C; Xiao Y; Li R; Ma X; Xue Y; Zhang Q; Lv J; Tan Q; Zhu Z; Song X; Tan J
    Cytokine; 2014 Sep; 69(1):6-13. PubMed ID: 25022956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma.
    Kasashima H; Yashiro M; Nakamae H; Masuda G; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
    PLoS One; 2017; 12(6):e0178635. PubMed ID: 28575019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A C-X-C Chemokine Receptor Type 2-Dominated Cross-talk between Tumor Cells and Macrophages Drives Gastric Cancer Metastasis.
    Zhou Z; Xia G; Xiang Z; Liu M; Wei Z; Yan J; Chen W; Zhu J; Awasthi N; Sun X; Fung KM; He Y; Li M; Zhang C
    Clin Cancer Res; 2019 Jun; 25(11):3317-3328. PubMed ID: 30796034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL1-Chemokine (C-X-C Motif) Receptor 2 Signaling Stimulates the Recruitment of Bone Marrow-Derived Mesenchymal Cells into Diffuse-Type Gastric Cancer Stroma.
    Kasashima H; Yashiro M; Nakamae H; Kitayama K; Masuda G; Kinoshita H; Fukuoka T; Hasegawa T; Nakane T; Hino M; Hirakawa K; Ohira M
    Am J Pathol; 2016 Nov; 186(11):3028-3039. PubMed ID: 27742059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCR2-driven ovarian cancer progression involves upregulation of proinflammatory chemokines by potentiating NF-κB activation via EGFR-transactivated Akt signaling.
    Dong YL; Kabir SM; Lee ES; Son DS
    PLoS One; 2013; 8(12):e83789. PubMed ID: 24376747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
    Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
    Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL1 from tumor-associated lymphatic endothelial cells drives gastric cancer cell into lymphatic system via activating integrin β1/FAK/AKT signaling.
    Wang Z; Wang Z; Li G; Wu H; Sun K; Chen J; Feng Y; Chen C; Cai S; Xu J; He Y
    Cancer Lett; 2017 Jan; 385():28-38. PubMed ID: 27832972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis.
    Xiang Z; Zhou ZJ; Xia GK; Zhang XH; Wei ZW; Zhu JT; Yu J; Chen W; He Y; Schwarz RE; Brekken RA; Awasthi N; Zhang CH
    Oncogene; 2017 Sep; 36(36):5122-5133. PubMed ID: 28481874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastric cancer.
    Xu J; Zhang C; He Y; Wu H; Wang Z; Song W; Li W; He W; Cai S; Zhan W
    Int J Cancer; 2012 Feb; 130(4):787-97. PubMed ID: 21387301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
    Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
    J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
    Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
    Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unsaturated Aldehyde Acrolein Promotes Retinal Glial Cell Migration.
    Murata M; Noda K; Yoshida S; Saito M; Fujiya A; Kanda A; Ishida S
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4425-4435. PubMed ID: 31652327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased chemokine receptor IL-17RA expression is associated with poor survival in gastric cancer patients.
    Jiang YX; Li PA; Yang SW; Hao YX; Yu PW
    Int J Clin Exp Pathol; 2015; 8(6):7002-8. PubMed ID: 26261590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL1 contributes to β-amyloid-induced transendothelial migration of monocytes in Alzheimer's disease.
    Zhang K; Tian L; Liu L; Feng Y; Dong YB; Li B; Shang DS; Fang WG; Cao YP; Chen YH
    PLoS One; 2013; 8(8):e72744. PubMed ID: 23967336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients.
    Wang Z; Liu H; Shen Z; Wang X; Zhang H; Qin J; Xu J; Sun Y; Qin X
    BMC Cancer; 2015 Oct; 15():766. PubMed ID: 26497045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.
    Chen L; Gu J; Qian Y; Li M; Qian Y; Xu M; Li J; Wen Y; Xia L; Li J; Xia Q; Kong X; Wu H
    Cell Mol Gastroenterol Hepatol; 2019; 7(3):623-639. PubMed ID: 30630119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.